Background and purpose
Attention is one of the major cognitive domains adversely affected in multiple sclerosis (MS). The aim of the current study was to determine the effect of a single dose of methylphenidate on cognitive performance of MS patients with significant attention deficit.
In a double-blind placebo-controlled study design, 26 MS patients with impaired attention were randomly assigned to receive a single dose of 10 mg methylphenidate or placebo. Attention was assessed using the paced auditory serial addition test for 3 and 2 s (PASAT3″ and PASAT2″) at baseline and 1 h after drug/placebo administration.
Methylphenidate significantly improved performance of both PASAT3″ and PASAT2″ tests by 22.8% and 25.6% respectively (p<0.001), while no significant changes were observed in placebo treated patients.
Administration of a single dose of methylphenidate significantly improved attention in MS patients with considerable attention deficit.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.Neurology. 1991; 41: 685-691
- Neuropsychological aspects of multiple sclerosis.Neuropsychol Rev. 1998; 8: 43-77
- Cognitive functions in recent-onset demyelinating diseases.Arch Neurol. 1986; 43: 1138-1141
- Cognitive impairment in probable multiple sclerosis.J Neurol Neurosurg Psychiatry. 2003; 74: 443-446
- Attention impairment in recently diagnosed multiple sclerosis.Eur J Neurol. 1998; 5: 61-66
- Neuronal mechanisms of action of amphetamine.in: Creese I. Stimulants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York1983: 81-129
- Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.Behav Brain Res. 1998; 94: 127-152
- Methylphenidate and information processing. Part I: Differentiation between responders and nonresponders; part 2: efficacy in responders.J Clin Exp Neuropsychol. 1994; 16: 877-897
- A divided attention analysis of the effects of methylphenidate on the arithmetic performance of children with attention deficit hyperactivity disorder.J Child Psychol Psychiatry. 1991; 32: 463-471
- Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review.J Child Psychol Psychiatry. 1996; 37: 971-987
- Psychostimulant use in the rehabilitation of individuals with traumatic brain injury.J Head Trauma Rehabil. 2002; 17: 284-299
- Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.J Clin Oncol. 1998; 16: 2522-2527
- Cortical reorganization during PASAT task in MS patients with preserved working memory functions.NeuroImage. 2006; 31: 686-691
- Polman CH. MS functional composite. Relation to disease phenotype and disability strata.Neurology. 2000; 54: 1233-1239
- New diagnostic criteria for multiple sclerosis: guidelines for research protocols.Ann Neurol. 1983; 13: 227-231
- Cognitive function study group of the national multiple sclerosis society. A manual for the brief repeatable battery of neuropsychological test in multiple sclerosis.Medical College of Wisconsin, Milwaukee, WI1990
- Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.Neurosci Biobehav Rev. 2006; 30: 1225-1245
- Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.Clin Neurophysiol. 2004; 115: 188-193
- Electrophysiological indices of information processing in methylphenidate responders.Biol Psychiatry. 1997; 42: 434-445
- Differential cognitive impairment for diverse forms of multiple sclerosis.BMC Neurosci. 2006; 7: 39
- Long-latency cerebral event-related potentials in multiple sclerosis.J Clin Neurophysiol. 2001; 18: 372-377
Accepted: August 20, 2008
Received in revised form: August 3, 2008
Received: March 30, 2008
© 2008 Elsevier B.V. Published by Elsevier Inc. All rights reserved.